Research Projects

Filters

Filters for Projects
Research Units
NESP 4.12: Mitigating the impacts of extreme weather events on spectacled flying-foxes
Susan Laurance - Zoology & Ecology
01 Apr 2024 - 31 Mar 2027
Spectacled flying-foxes (SFFs) were listed as Endangered in 2019, following an extreme heatwave in 2018 that resulted in the death of approximately one-third of the population. The mass mortality of Australian flying-foxes at roosts during heatwaves has been well documented, with future extreme heat events considered the greatest threat to their survival. This project aims to improve our understanding of the local thermal environments of SFF roosts across their range, which is a critical aspect of their sensitivity to the increasing risks imposed by climate change. By doing so, this project will improve species management through the provision of tools to mitigate the devastating impacts of future extreme heatwaves and advise managers on effective interventions. This project addresses national priorities by providing adaptive solutions to support the recovery of a threatened species and in developing capacity to help reverse the decline in Australia’s natural environment.
Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study
Leanne Hall - Mackay Clinical School
01 Jun 2024 - 31 May 2026
This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.
Dugong tagging expedition in the Bazaruto Archipelago National Park (Mozambique)
James Cook University dugong research leader Dr Christophe Cleguer will be providing on-the-ground assistance to Africa Parks to coordinate the first ever dugong satellite tracking study in Africa. JCU and African Parks will carry out an innovative conservation initiative with the placement of satellite tracking tags with the aim of monitoring and thus better protecting the Dugong population in the Bazaruto Archipelago National Park (PNAB), Mozambique
Modelling plasma devices on femtosecond to millisecond timescales for compact particle-accelerator applications.
Greg Boyle - Physics
01 Jan 2024 - 31 Dec 2024
Australia-Germany Joint Research Cooperation Scheme 2023: Short-term exchange of researchers between JCU and DESY, collaborating on plasma wakefield acceleration (PWFA) research and development. JCU student to benefit from DESY experimental and simulation expertise as world leaders in PWFA, and DESY postdoc to benefit from JCU expertise on charged-particle transport theory.
Development of bivalent degraders targeting Aurora kinase A for the treatment of polycystic kidney disease (Old ID 31137)
Andrew Mallett - Medicine
01 Jan 2023 - 31 Dec 2025
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common, potentially fatal, monogenic disease. It is characterised by hyperproliferative formation of fluid-filled cysts from renal epithelia, which progressively ablate healthy renal tissue requiring dialysis or renal transplant to prevent death. It affects 1 in 500-1000 Australians and makes up 5% of end stage renal disease patients. The only approved therapy is a drug called tolvaptan, which inhibits the vasopressin receptor, thereby treating a symptom. Unsurprisingly, tolvaptan has only modest benefits, increasing patient lifespan by ~2.6 years at a cost of US$744K per quality-of-life-year gained. The drug has considerable side effects, including the potential for liver toxicity, with a borderline cost-benefit-risk profile. Consequently, ~24% patients discontinue use. Recently, a Phase II/III trial of Sanofi’s heralded breakthrough therapy, venglustat, was halted due to failure to prevent cyst growth. Rapamycin has also failed in clinical trials previously. As such, any therapeutic treatment that could halt/slow disease progression would be paradigm-shifting to meet this unmet need. We have shown that ADPKD can be halted by genetic ablation of Aurora kinase A (AURKA). Thus, AURKA is a key driver of this disease. We have now developed a small molecule that potently degrades AURKA at low nanomolar levels. This targeted protein degrader (TPD), which we call TPD100, is on the precipice of a significant value inflexion point that will be realized through the combination of its current in vitro cell-based and in vivo potency, combined with a future strong intellectual property position, and evidence of efficacy and safety in ADPKD animal models. This grant will support the development of a novel and patent-protected TPD that is safe and efficacious in ADPKD animal models with once-weekly subcutaneous dosing, representing a very attractive investment package as we progress towards a human ADPKD therapy.
Long-term effects of sea-weeding on degraded coral reefs
Hillary Smith - Marine Biology & Aquaculture
01 Oct 2024 - 30 Sep 2029
Coral reefs around the world are under threat from the combined impacts of climate change and local stressors. Often, when corals die, macroalgae (seaweeds) rapidly take over available space on a reef, with corals struggling to regain dominance once seaweeds are established. My research has shown that a low-tech, simple approach of “sea-weeding” (i.e. removing seaweed by hand) is effective in rapidly rehabilitating degraded, macroalgae-dominated reefs. Over five years, my research program on two degraded reefs of Australia’s Great Barrier Reef saw a >600% increase in coral cover where macroalgae were removed three times annually, while no change was observed in control plots. These spectacular results provide an exciting potential management approach for other seaweed-dominated areas, as sea-weeding can be achieved through collective action via citizen science. However, because reef recovery dynamics operate on decadal time-scales, it is critical to understand the long-term effects of intervention via sea-weeding. In this project, I will extend the timeframe of the established sea-weeding experiment to document the trajectory of reef recovery. Specifically, the project will transition into a "maintenance" phase of weeding once per year (rather than 2-3 times per year in the first 5 years) to establish the efficacy of less frequent intervention. The results will help inform the best-practice application of sea- weeding in reef management strategies.
Megalithic connections: Investigation and Digital Conservation of imperilled cultural heritage in Laos and India (Old ID 27791)
Kate Domett - Anatomy & Pathology
01 Jan 2023 - 31 Dec 2027
This interdisciplinary project aims to explore the cultural connections between the geographically disparate megalithic cultures of Laos and India and to create an enduring digital record of these threatened cultural assets. Using archaeological science and pioneering technologies the project will create new knowledge, museum exhibitions, strengthening cultural relations and public diplomacy. The research will advance archaeological knowledge, heritage management processes and lead to economic, social and cultural benefit in these regions. With an increasing awareness of the need to protect and conserve global cultural assets, there is an opportunity for Australia to take a lead in developing innovative technological solutions.
Development and Evaluation of Lived Experience Peer Support Intervention for Mental Health Service Users in Primary Care
Sam Manger - Medicine
01 Jan 2023 - 31 Dec 2025
2 aspects to this project including a primary care co-design phase and then an intervention phase, with the overall goal of hosting peer support workers in primary care to provide mental health support. Lived experience peer support has been used in many mental healthcare contexts, but not in primary care. Peers walk alongside consumers to improve their self-efficacy and personal recovery. Peer support will improve access, engagement and support for people with mental ill-health in primary care.
Blended Living Lab for Nurturing Circular-Entrepreneurships among Australian and Arab Entrepreneurs
Eijaz Khan - Management & Tourism
31 May 2024 - 31 Oct 2025
To promote circular-entrepreneurship on the Australian-Arab, a Blended Living Lab (BLL) will be established in collaboration with James Cook University, Abu Dhabi University, UAE, and King Abdul Aziz University, Saudi Arabia. To accomplish this, First, the BLL will conduct three workshops with 30 attendees each in the UAE, Saudi Arabia, and Australia, organise 5-6 online knowledge sharing sessions, and create a portable training package called 'Designing Circularity into Business Models and Products' (DCBMP). Second, using DCBMP, we will conduct one online training sessions to build the capacity of 30 entrepreneurs in circular business models/products to accelerate innovation and create startups. Third, upon completion of the project, the BLL will be equipped with world-class online labs, and we will brand/market the BLL subscription model globally/Arab regions at nominal fees. Finally, through this approach, our project aims to enhance awareness/understanding among Australian-Arabs, maximise public diplomacy/economic opportunities, build strong community/institutional relationships, and increase recognition in the Arab.
Prevalence of anorectal Chlamydia Trachomatis infection in asymptomatic urogenital Chlamydia Trachomatis positive women who present to regional North Queensland Sexual Health Services.
Carol Flavell - Physiotherapy
23 Feb 2024 - 28 Jul 2028
This study will investigate and report the rates of confirmed anorectal chlamydia trachomatis (CT) infection in women who attend one of two regional North Queensland sexual health services (SHS). The research will focus on women who are confirmed to have urogenital CT infection following routine testing at the SHS, but they report no symptoms of CT prior to testing, and have not participated in any anal sexual contact in the previous six months. Findings have potential to influence future testing and management guidelines for management of CT in this group of women.